Cell and Molecular Biology: Chromosomes, Cancer and Stem Cells

描述（由申请人提供）：纽约科学院与细胞生物学杂志合作，正在计划一个重要的2.5天的会议，题为“疾病的细胞生物学：染色体，癌症和干细胞。“这次会议将于2009年9月在纽约市的纽约科学院会议中心举行。这项资助的主要研究者是加州大学伯克利分校细胞与发育生物学教授Rebecca Heald。 研讨会将重点放在基础科学上，但将提供一些与后续临床应用的整合，以便实验室研究人员和临床医生能够对基础研究转化为有效治疗方法的潜力形成相互理解。我们会议的目标是介绍和传播有关细胞生物学和疾病的信息。该计划将解决我们在细胞和分子水平上对疾病病理学的理解的最新进展，重点是癌症。演讲者将讨论由染色体异常，DNA修复机制缺陷和其他核异常引起的疾病。会议还将强调干细胞研究的进展，重点是其在癌症和疾病中的应用。最后，这次会议的一个主要目标是突出目前在这一领域工作的最优秀和最聪明的年轻科学家。 与会者应实现我们的理解疾病的分子和细胞病理学的最新突破的赞赏。会议将包括主旨演讲，全体演讲，海报展示的组合，并将以互动小组讨论达到高潮。这次会议是精心策划的，包括充分的机会建立联系。我们预计，会议将吸引在分子生物学，细胞生物学和免疫学领域工作的高级研究人员，博士后研究员和行业科学家的广泛参与。 公共卫生相关性：我们2.5天会议的目标是讨论细胞生物学和疾病。该计划将解决我们在细胞和分子水平上对疾病病理学的理解的最新进展，重点是癌症。会议将汇集来自各种不同背景和领域的专家，讨论这一重要的统一主题。

DESCRIPTION (provided by applicant): The New York Academy of Sciences in partnership with the Journal of Cell Biology is planning an important 2.5-day conference entitled, "Cell Biology of Disease: Chromosomes, Cancer and Stem Cells." This meeting will be held in September, 2009 at the New York Academy of Sciences Conference Center in New York City. The principal investigator for this grant is Rebecca Heald, Professor of Cell and Developmental Biology at UC Berkeley. The symposium will focus on basic science, but will provide some integration with subsequent clinical applications so that bench researchers and clinicians can develop a mutual understanding of the potential for translation of basic research into effective therapeutics. The goal of our conference is the presentation and dissemination of information about cell biology and disease. The program will address recent advances in our understanding of disease pathology at the cellular and molecular level, with a focus on cancer. Presenters will discuss diseases caused by chromosomal abnormalities, DNA repair mechanism defects, and other nuclear irregularities. The meeting will also highlight progress in stem cell research with a focus on its application to cancer and diseases. Finally, a major goal of this meeting will be to highlight the best and brightest young scientists currently working in this field. Conference attendees should achieve an appreciation of the latest breakthroughs in our understanding of the molecular and cellular pathology of disease. The conference will include a combination of keynote addresses, plenary lectures, poster presentations and will culminate with an interactive panel discussion. The conference is carefully planned to include ample opportunities for networking. We anticipate that the conference will attract wide participation among senior investigators, post-doctoral fellows, and industry scientists working in the fields of molecular biology, cell biology, and immunology. Public Health Relevance: The goal of our 2.5 day conference is to discuss cell biology and disease. The program will address recent advances in our understanding of disease pathology at the cellular and molecular level, with a focus on cancer. The meeting will bring together experts from a variety of different backgrounds and fields to discuss this important unifying theme.